SynthesisFrontiers in oncology2020

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials.

Li Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.